Cargando…
Insulin‐derived amyloidosis without a palpable mass at the insulin injection site: A report of two cases
To date, almost all case reports of insulin‐derived amyloidosis described the presence of a subcutaneous mass that was observable on physical examination. This report presents two cases of insulin‐derived amyloidosis without palpable masses at insulin injection sites. In both cases, blood glucose co...
Autores principales: | Nagase, Terumasa, Iwaya, Keiichi, Kogure, Koichiro, Zako, Tamotsu, Misumi, Yohei, Kikuchi, Minoru, Matsumoto, Koichi, Noritake, Masayuki, Kawachi, Yasuhiro, Kobayashi, Masaki, Ando, Yukio, Katsura, Yoshiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378411/ https://www.ncbi.nlm.nih.gov/pubmed/31867887 http://dx.doi.org/10.1111/jdi.13199 |
Ejemplares similares
-
Toxicity of insulin-derived amyloidosis: a case report
por: Iwaya, Keiichi, et al.
Publicado: (2019) -
Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates
por: Mori, Wakako, et al.
Publicado: (2021) -
Insulin amyloid polymorphs: implications for iatrogenic cytotoxicity
por: Yuzu, Keisuke, et al.
Publicado: (2020) -
Multiple Endocrine Neoplasia Type 1 with Functional Parathyroid Cysts
por: Koyama, Nobuyuki, et al.
Publicado: (2021) -
Erratum for
Multiple Endocrine Neoplasia Type 1 with Functional Parathyroid Cysts
por: Koyama, Nobuyuki, et al.
Publicado: (2022)